Defecation disorders: neuromuscular aspects and treatment.
Chronic constipation and fecal incontinence affect 20% of the population and are more prevalent in women, the elderly, those of lower socioeconomic status, and nursing home residents. These disorders pose a significant economic burden and affect quality of life. During the past decade, significant strides have been made in the understanding and treatment of defecation disorders, which have led to real advances in the management of these disorders. These treatments include biofeedback therapy, tegaserod, and lubiprostone for chronic constipation.
Remes-Troche
Jose M
JM
GI Division, The University of Iowa Hospital & Clinics, Iowa City, IA 52242, USA.
Rao
Satish S C
SS
D001676:Biofeedback, Psychology / Q000379:methods*; D003248:Constipation / Q000503:physiopathology / Q000628:therapy*; D003672:Defecation / Q000502:physiology*; D013505:Digestive System Surgical Procedures / Q000379:methods*; D005242:Fecal Incontinence / Q000503:physiopathology / Q000628:therapy*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D016896:Treatment Outcome
D005765:Gastrointestinal Agents